Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Melanoma 57Carcinoma, Renal Cell 19Leukemia, Myeloid, Acute 15Lymphoma, Non-Hodgkin 10Leukemia 10Kidney Neoplasms 10Skin Neoplasms 9Neuroblastoma 9Neoplasms 9Neoplasm Metastasis 9Lymphoma 9Breast Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 6Recurrence 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Myelodysplastic Syndromes 5Congenital Abnormalities 5Uveal Melanoma 4Multiple Myeloma 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Hodgkin Disease 4Hematologic Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 2

Interventions

Sunitinib 4Nivolumab 4pazopanib 3Radiosurgery 3Ipilimumab 3Radiopharmaceuticals 1Molecular Imaging 1Interleukin-2 1Everolimus 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Clear-cell metastatic renal cell carcinoma × Interleukin-2 × Clear all
NCT01896271 2021-08-23

High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer

University of Texas Southwestern Medical Center

Phase 2 Completed
30 enrolled 12 charts
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡